Phenotype Manipulation by Gene Transfer in Animals - Review -

Asian-Australasian Journal of Animal Sciences

Volumn 13, Issue 2, 2000, Pages 244-257

  Fujiwara, Y ^a   Park, H M ^a   Muramatsu, T ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

Genuine Transgenic; Localized In Vivo Gene Transfer; Recombinant Protein Production; Somatotransgenic; Transfectgenic; Xenotransplantation

Indexed keywords

EID: 0346438853     PISSN: 10112367     EISSN: None     Source Type: Journal    
DOI: 10.5713/ajas.2000.244     Document Type: Review

References (141)

1. Aihara, H. and J. Miyazaki. 1998. Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16:867-70.
2. Archer, J. S., W S. Kennan, M. N. Gould and R. D. Bremel. 1994. Human growth hormone (hGH) secretion in milk of goats after direct transfer of the hGH gene into the mammary gland by using replication-defective retrovirus vectors. Proc. Natl. Acad. Sci. USA, 91: 6840-6844.
3. Baguisi, A., E. Beboodi, D. T. Melican, J. S. Pollock, M. M. Destrempes, C. Cammuso, J. L. Williams, S. D. Nims, C. A. Porter, P. Midura, M. J. Palacios, S. L. Ayers, R. S. Denniston, M. L. Hayes, C. A. Ziomek, H. M. Meade, R. A. Godke, W. G. Gavin, E. R. Overstrom and Y. Echelard. 1999. Production of goats by somatic cell nuclear transfer. Nat. Biotechnol. 17:456-461.
4. Barash, I., N. Ilan, R. Kari, D. R. Hurwitz and M. Shani 1996. Co-integration of β-lactoglobulin/human serum albumin hybrid genes with the entire β-lactoglobulin gene or the matrix attachment region element: repression of human serum albumin and β-lactoglobulin expression in the mammary gland and dual regulation of the transgenes. Mol. Reprod. Dev. 45:421-430.
5. Belehradek, M., C. Domenge, B. Luboinski, S. Orlowski, J. Belehradek, Jr. and L. M. Mir. 1993. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer. 72:3694-3700.
6. Bijvoet, A. G. A., M. A. Kros, F. R. Pieper, H. A. de Boer, A. J. J. Reuser, A. T. der Ploeg and M. P. Verbeet. 1996. Expression of cDNA-encoded human acid α-glucosidase in milk of transgenic mice. Biochim. Biophys. Acta. 1308:93-96.
7. Boulikas, T. 1997. Gene therapy of prostate cancer: p53, suicidal genes, and other targets. Anticancer Res. 17: 1471-1505.
8. Brem, G., P. Hartl, U. Besenbfelder, E. Wolf and N. Zinovieva. 1994. Expression of synthetic cDNA sequences encoding human insulin-like growth factor- I (IGF- I) in the mammary gland of transgenic rabbits. Gene. 149:351-355.
9. Brinster, R. L., J. M. Allen, R. R. Behringer, R. E. Gelinas and R. D. Palmiter. 1988. Introns increase transcriptional efficiency in transgenic mice. Proc. Natl. Acad. Sci. USA. 85:836-840.
10. Buhler, T. A, T. Bruyere, D. F. Went, G. Stranzinger and K. Burki. 1989. Rabbit β-casein promoter directs secretion of human interleukin-2 into the milk of transgenic rabbits. Biotechnology. 8:140-144.
11. Calne, R. Y. 1970. Organ transplantation between widely disparate species. Transplant. Proc. 2:550-553.
12. Campbell, K. H. S., J. McWhir, W. A. Ritchie and I. Wilmut. 1996. Sheep cloned by nuclear transfer from a cultured cell line. Nature. 380:64-66.
13. Carry, N., J. Moody, N. Yannoutsos, J. Wallwork and D. White. 1993. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection. Transplant. Proc. 25:400-401.
14. Chen C. -G, E. J. Salvaris, M. Romanella, A. Aminian, M. Katerelos, N. Fisicaro, A. J. F. D'Apice, and M. J. Pearse. 1998. Transgenic expression of human of α1,2-fucosyltransferase (H-transferase) prolongs mouse heart survival in an ex vivo model of xenograft rejection. Transplantation. 65:832-837.
15. Chong, H. and R. G. Vile. 1996. New therapeutic approaches based on gene trangfer technologies. Springer. Semin. Immunopathol. 18:149-170.
16. Cibelli, J. B., S. L. Stice, P. J. Golueke, J. J. Kane, J. Jerry, C. Blackwell, F. A. Ponce de Leon and J. M. Robl. 1998. Cloned transgenic calves produced from nonquiescent fetal fibroblasts. Science. 280:1256-1258.
17. Clark, A. J., A. Cowper, R. Wallace, G. Wright and J. P. Simons. 1992. Rescuing transgene expression by co-injection. Bio/Technology. 10:1450-1454.
18. Cockerill, P. N. and W. T. Garrard. 1986. Chromosomal loop anchorage of the kappa immunogloblin gene occurs next to the enhancer in a region containing topoisomerase II site. Cell. 44:273-282
19. Cooper, D. K. C., E. Koren and R. Oriol. 1994. Oligosaccharides and discordant xenotransplantation. Immunol. Rev. 141:31-58.
20. Cooper, D. K. C., Y. Ye, L. L. Rolf and N. Zuhdi. 1991. The pig as potential organ donor for man. In: Xenotransplantation. Cooper, D. K. C., E. Kemp, K. Reemtsma and D. J. G. White eds. Springer-Verlag, pp. 481-500.
21. Coulibaly, S., U. Besenfelder, M. Fleischmann, N. Zinovieva, A. Grossmann, M. Wozny, I. Bartke, R. Toegel, M. Muller and G. Brem. 1999. Human nerve growth factor beta (hNGF-b): mammary gland specific expression and production in transgenic rabbits. FEBS Lett. 444:111-116.
22. Cowan P. J., C.-G. Chen, T. A. Shinkel, N. Fiscaro, E. Salvaris, A. Aminian, M. Romanella, M. J. Pearse, and A. J. F. D'Apice. 1998. Knock out of α1,3-galactosyltransferase or expression of α1,2-fucosyltransferase further protects CD55- and CD59-expressing mouse hearts in an ex vivo model of xenograft rejection. Transplantation. 65:1599-1604.
23. Dalmasso, A. P., G. M. Vercellotti, R. J. Fiscehel, R. M. Bolman, F. H. Bach and J. L. Platt. 1992. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am. J. Pathol. 140:1157-1166.
24. Dalmasso, A. P., G. M. Vercellotti, J. L. Platt and F. H. Bach. 1991. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-acceleration factor. Transplantation. 52:530-533.
25. Davis, H. L., M. L. Michel, M. Mancini, M. Schleef and R. G. Whalen. 1994. Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine. 12:1503-1509.
26. Devinoy, E., D. Thepot, M. G. Stinnakre, M. L. Fontaine, H. Grabowski, C. Puissant, A. Pavirani and L. M. Houdebine. 1994. High level production of human growth hormone in the milk of transgenic mice: the upstream region of the rabbit whey acidic protein (WAP) gene targets transgene expression to the mammary gland. Transgenic Res. 3:79-89.
27. Diamond, L. E., E. R. Oldham, J. L. Waldmann, M. Tone, L. A. Walsh and J. S. Logan. 1994. Cell- and tissue-specific expression of a human CD59 minigene in transgenic mice. Transplant. Proc. 26:1239.
28. Dube, I. D. and D. Cournoyer. 1995. Gene therapy:here to stay. Can. Med. Assoc. J. 152:1605-1613.
29. Dzau, V. J., R. Morishita and G. H. Bibbons. 1993. Gene therapy for cardiovascular disease. Trends Biotechnol. 11: 205-210.
30. Ebert, K. M., P. DiTullio, C. A. Barry, J. E. Schindler, S. I. Ayres, T. E. Smith, L. J. Pellerin, H. M. Meade, J. Denman and B. Roberts. 1994. Induction of human tissue plasminogen activator in the mammary gland of transgenic goats. Bio/Technology. 12:699-702.
31. Edmunds, T., S. M. V. Patten, J. Pollock, E. Hangon, R. Bernasconi, E. Higgins, P. Manavalan, C. Ziomek, H. Meade, J, M. McPherson and E. S. Cole. 1998. Transgenically produced human antithrombin: Structural and functional comparison to human plasma-derived antithrombin. Blood. 91:4561-4571.
32. Ellis, J., K. C. Tan-Un, A. Harper, D. Michalovich, N. Yannoutsos, S. Philipsen and F. Grosveld. 1996. A dominant chromatin-opening activity in 5' hypersensitive site 3 of human β-globin locus control region. EMBO. J. 15:562-568.
33. Felgner, P. L. 1997. Nonviral strategies for gene therapy. Sci. Am. 276:102-106.
34. Fodor, W. L., B. L. Williams, L. A. Matis, J. A. Madri, S. A. Rollins, J. W. Knight, W. Velander and S. P. Squinto. 1994. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc. Natl. Acad. Sci., USA. 91:11153-11157.
35. Friedmann, T. and H. A. Jinnah. 1993. Gene therapy for disorders of the nervous system. Trends Biotechnol. 11: 192-197.
36. Fujiwara, Y., M. Miwa, M. Nogami, K. Okumura, T. Nobori, T. Suzuki and M. Ueda. 1997a. Genomic organization and chromosomal localization of the human casein gene family. Human Genet. 99:368-373.
37. Fujiwara, Y., M. Miwa, R. Takahashi, M. Hirabayashi, T. Suzuki and M. Ueda. 1997b. Transgenic animals with various YAC constructs: Preparation of 400 kb YAC DNA for microinjection. J. Reprod. Dev. 43:81-90.
38. Fujiwara, Y., M. Miwa, R. Takahashi, M. Hirabayashi, T. Suzuki and M. Ueda. 1997c. Position-independent and high-level expression of human α-lactoglobumin in the milk of transgenic rats carrying a 210-kb YAC DNA. Mol. Reprod. Dev. 47:157-163.
39. Fujiwara, Y., M. Miwa, R. Takahashi, M. Kameda, K. Kodaira, M. Hirabayashi, T. Suzuki and M. Ueda. 1999b. Analysis of control elements for position-independent expression of human α-lactalbumin YAC. Mol. Reprod. Dev. 54:17-23.
40. Fujiwara, Y., M. Miwa, R. Takahashi, K. Kodaira, M. Hirabayashi, T Suzuki and M. Ueda. 1999a. High-level expressing YAC vector for transgenic animal bioreactor. Mol. Reprod. Dev. 52:414-420.
41. Gasser, S. M. and U. K. Laemmli. 1986. Cohabitation of scaffold binding regions with upstream/enhancer elements of three developmentally regulated genes of D. melanogaster. Cell. 46:521-530.
42. Giralt, M., A. E. Park, J. Liu, A. Gurney and R. W. Hanson. 1991. Identification of a thyroid hormone response element in P-enolpyruvate carboxykinase (GTP) gene: evidence for a synergistic interaction between thyroid hormone and cAMP cis regulatory elements. J. Biol. Chem. 266:21991-21996.
43. Groenen, M. A. M. and J. J. van der Pool. 1994. Regulation of expression of milk protein genes: a review. Livest. Prod. Sci. 38:61-78.
44. Grosveld, F., G. B. van Assendelft, D. Greaves and G. Kollias. 1987. Position-independent, high-level expression of the human β-globin gene in transgenic mice. Cell. 51:975-985.
45. Harris, M. P., S. Sutjipto, K. N. Wills, W. Hancock, D. Cornell, D. E. Johnson, R. J. Gregory, H. M. Shepard and D. C. Maneval. 1996. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Cancer Gene Therapy. 3:121-130.
46. Heller, R., M. Jaroszeski, A. Atkin, D. Moradpour, R. Gilbert, J. Wands and C. Nicolau. 1996. In vivo gene electroinjection and expression in rat liver. FEBS Lett. 389:225-228.
47. Houdebine, L. M. 1994. Production of pharmaceutical proteins from transgenic animals. J. Biotech. 34:269-287.
48. Hsiao, M., V. Tse, J. Carmel, Y. Tsai, P. L. Felgner, M. Haas and G. D. Silverberg. 1997. Intracavitary liposome-mediated p53 gene transfer into glioblastoma with endogenous wild-type p53 in vivo results in tumor suppression and long-term suvival. Biochem. Biophys. Res. Commun. 233:359-364.
49. Hulsey, M. G., R. J. Martin and C. A. Baile. 1996. The role of transgenic models in nutrition research. In : Gene Expression and Nutrition : From Cells to Whole- Body. Muramatsu, T.ed., Reserach Signpost, Trivandrum, India. pp. 103-123.
50. Hurwitz, D., M. Mathan, I. Barash, N. Ilan and M. Shani. 1994. Specific combinations of human serum albumin introns direct high level expression of albumin in transfected COS cells and in the milk of transgenic mice. Transgenic Res. 3:365-375.
51. John, D. C. A. R. Watson, A. J. Kind, A. R. Scott, K. E. Kadler and N. J. Bulleid. 1999. Expression of an engineered form of recombinant procollagen in mouse milk. Nature Biotech. 17:385-389.
52. Johnston, P. S., M. W. Wang, S. M. L. Lim, L. J. Wright and D. J. G. White. 1992. Discordant xenograft rejection in an antibody free model. Transplantation. 54:573-576.
53. Kato Y., T. Tani, Y. Sotomaru, K. Kurokawa, J. Kato, H. Doguchi, H. Yasue and Y. Tsunoda. 1998. Eight calves cloned from somatic cells of a single adult. Science. 282: 2095-2098.
54. Kellum, R. and P. Shedl. 1991. A position-effect assay for boundaries of higher order chromosomal domains. Cell. 64:941-950.
55. Kerr, D. E., F. Liang, K. R. Bondioli, H. Zhao, G. Kreibich, R. J. Wall and T. T. Sun. 1998. The bladder as a bioreactor: urothelium production and secretion of growth hormone into urine. Nature Biotech. 16:75-79.
56. Kistner, T., M. Gossen, F. Zimmermann, J. Jerecic, C. Ullmer, H. Lubbert and H. Bujard. 1996. Doxycyclin-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci., USA. 93:10933-10938.
57. Korhonen, V. P., M. Tolvanen, J. M. Hyttinen, M. Uusi-Oukari, R. Sineivirta, L. Alhonen, M. Jauhiainen, O. A. Janne and J. Janne. 1997. Expression of bovine β -lactoglobulin/human erythropoietin fusion protein in the milk of transgenic mice and rabbits. Eur. J. Biochem. 245:482-489.
58. Krnacik, M. J., S. Li, J. Liao and J. M. Rosen. 1995. Position-independent expression of whey acidic protein tansgenes. J. Biol. Chem. 270:11119-11129.
59. Lagutin, O. V., V. N. Dobrovolsky, T. V. Vinogradova, B. N. Kyndiakov, Y. M. Khodarovich, N. Jenkins, D. James, N. Markham and O. A. Larionov. 1999. Efficient human IFN-γ expression in the mammary gland of transgenic mice. J. Interferon Cytosine Res. 19:137-144.
60. Lambrigts D., D. H. Sachs and D. K. C. Cooper. 1998. Discordant organ xenotransplantation in primates. Transplantation. 66:547-561.
61. Langford, G. A. E. Cozzi, N. Yannoutsos, R. Lancaster, K. Elsome, P. Chen and D. J. G. White. 1996. Production of pigs transgenic for human regulators of complement activation using YAC technology. Transplant. Proc. 28: 862-863.
62. Larsen, R. D., C. A. Rivers-Marrero, L. K. Ernst, R. D. Cummings and J. B. Lower. 1990. Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal: β-D-Gal(1,4)-D-GlcNAc α(1,3)-galactosyltransferase. J. Biol. Chem. 265: 7055-7061.
63. Ludwig, D. L., J. R. Stringer, D. C. Wight, T. C. Doetschman and J. J. Duffy. 1996. FLP-mediated site-specific recombination in microinjected murine zygotes. Transgenic Res. 5:385-395.
64. Maga, E. A., G. B. Anderson and J. D. Murray. 1995. The effect of mammary gland expression of human lysozyme on the properties of milk from transgenic mice. J. Dairy Sci. 78:2645-2652.
65. Marrero, M. B., B. Schieffer, W. G. Paxton, E. Schieffer and K. E. Bernstein. 1995. Electroporation of pp60c-src antibodies inhibits the angiotensin II activation of phospholipase C-gamma I in rat aortic smooth muscle cells. J. Biol. Chem. 270:15734-15738.
66. McGrane, M. M., J. de Vente, J. Yun, J. Bloom, E. A. Park, A. Wynshaw-Boris, T. Wagner, F. M. Rottman and R. W. Hanson, 1988. Tissue-specific expression and dietary regulation of a chimeric PEPCK/bGH gene in transgenic mice. J. Biol. Chem. 263:11443-11451.
67. McKee, C., A. Gibson, M. Dalrymple, L. Emslie, I. Garner and I. Cottingham. 1998. Production of biologically active salmon calcitonin in the milk of transgenic rabbits. Nature Biotech. 16:647-651.
68. McKnight, R. A., A. Shamay, L. Sankaran, R. J. Wall and L. Hennighausen. 1992. Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in trassgenic mice. Proc. Natl. Acad. Sci. USA. 89:6943-6947.
69. McNearney, T., L. Ballard, T. Seya and J. P. Atkinson. 1989. Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells. J. Clin. Invest. 84:538-545.
70. McKnight, R. A., R. J. Wall and L. Hennighausen. 1995. Expression of genomic and cDNA, transgenes after co-integration in transgenic mice. Transgenic Res. 4:39-43.
71. 1-casein gene sequences direct high level expression of active human urokinase in mouse milk. Bio/Technology. 8:443-446.
72. Mir, L. M., S. Orlowski, J. Belehradek Jr. and C. Paoletti. 1991. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur. J. Cancer. 27:68-72.
73. Mitani, K. and C. T. Caskey. 1993. Delivering therapeutic genes - matching approach and application. Trends Biotechnol. 11:162-166.
74. Mulligan, R. C. 1993. The basic science of gene therapy. Science. 260:926-932.
75. Muramatsu, T., Y. Mizutani and J. Okumura. 1996a. Live detection of firefly luciferase gene expression by bioluminescence in incubating chicken embryos. Anim. Sci. Technol. Jpn. 67:906-909.
76. Muramatsu, T., V. Mizutani, Y. Ohmori and J. Okumura. 1997c. Comparison of three non viral transfection methods for foreign gene expression in early chicken embryos in ovo. Biochem. Biophys. Res. Commun. 230:376-380.
77. Muramatsu, T. and A. Nakamura. 1997. Production of transgenic cattle as an animal bioreactor : current status and perspective. Trends Comp. Biochem. Physiol. 3:9-21.
78. Muramatsu, T., A. Nakamura and H. -M. Park. 1998a. In vivo electroporation : a powerful and convenient means of nonviral gene transfer to tissues of living animals. Int. J. Mol. Med. 1:55-62.
79. Muramatsu, T., A. Nakamura and H. -M. Park. 1998b. Basics and applications of gene transfer in animal cells and tissues for production and therapeutics. J. Mainm. Ova Res. 15:1-16.
80. Muramatsu, T. and M. M. Sanders. 1995. Regulation of ovalbumin gene expression. Poult. Avian Biol. Rev. 6: 107-123.
81. Muramatsu, T., O. Shibata, Y. Ohmori and J. Okumura. 1996b. In vivo electroporation : a convenient method for gene transfer to testicular cells in mice. Anim. Sci. Technol Jpn. 67:975-982.
82. Muramatsu, T., O. Shibata and J. Okumura. 1997b. Effect of self-replication DNA sequences of Epstein-Barr virus on the expression of a foreign gene transfected in vivo to the mouse testis. Anim. Sci. Technol. Jpn. 68:650-654.
83. Muramatsu, T., O. Shibata, S. Ryoki, Y. Ohmori and J. Okumura. 1997a. Foreign gene expression in the mouse testis by localized in vivo gene transfer. Biochem. Biophys. Res. Commu. 233:45-49.
84. Nakanishi, M. 1995. Gene introduction into animal tissues. Crit. Rev. Ther. Drug Carrier Syst. 12:263-310.
85. Nicholson-Weller, A., J. Burge, D. T. Fearon, P. F. Weller and K. F. Austin. 1982. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J. Immunol. 129:184-189.
86. Nielsen, L. L., J. Dell, E. Maxwell, L. Armstrong, D. Maneval and J. J. Catino. 1997. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. Cancer Gene Ther. 4:129-138.
87. Nishi, T., K. Yoshizato, S. Yamashiro, H. Takeshima, K. Sato, K. Hamada, I. Kitamura, T. Yoshimura, H. Saya, J. Kuratsu and Y. Ushio. 1996. High- efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Res. 56:1050-1055.
88. Northrop, J. P, G. M. Ringlod and M. Danielsen. 1987. Lipofection: a highly efficient lipid-mediated DNA- transfection procedure. Proc. Natl. Acad. Sci., USA. 84:7413-7417.
89. Oglesby, T. J., C. J. Allen, M. K. Liszewski, D. J. G. White and J. P. Atkinson. 1992. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J. Exp. Med. 175: 1547-1551.
90. Okada, N., R. Harada, T. Fujita and H. Okada. 1989. A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int. Immunol. 1:205-208.
91. Orban, P. C., D. Chui and D. Marth. 1992. Tissue- and site-specific DNA recombination in transgenic mice. Proc. Natl. Acad. Sci., USA. 89:6861-6865.
92. Orlowski, S., J. Belehradek, Jr., C. Paoletti and L. M. Mir. 1988. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem. Pharmacol. 37:4727-4733.
93. Paleyanda, R. K., W. H. Velander, T. K. Lee, D. H. Scandella, F. C. Gwazdauskas, J. W. Knight, L. W. Hoyer, W. N. Drohan and H. Lubon. 1997. Transgenic pigs produce functional human factor VIII in milk. Nat. Biotech. 15:971-975.
94. Palmiter, R. D. and R. L. Brinster. 1986. Germ-line transformation of mice. Ann. Rev. Genet. 20:465-499.
95. Palmiter, R. D., E. P. Sandgren, M. R. Avarbock, D. D. Allen and R. L. Brinster. 1991. Heterologous intron can enhance expression of transgenes in mice. Proc. Natl. Acad. Sci., USA. 88:478-482.
96. Park, H. -M. and T. Muramatsu. 1999. In vivo manipulation of foreign gene expression by steroid administration in the oviduct of laying hens. J. Endocrionol. (In press).
97. Platenburg, G. J., E. P. A. Kootijk, P. M. Kooiman, S. L. Woloshuk, J. H. Nuijens, P. J. A. Krimpenfort, F. R. Pieper, H. A. de Boer and R. Strijker. 1994. Expression of lactoferrin in milk of transgenic mice. Transgenic Res. 3:99-108.
98. Prausnitz, M. R., V. G. Bose, R. Lulger and J. C. Weaver. 1993. Electroporation of mammalian skin : a mechanism to enhance transdermal drug delivery. Proc. Natl. Acad. Sci., USA. 90:10504-10508.
99. Prunkard, D., I. Cottingham, I. Gamer, S. Bruce, M. Dalrymple, G. Lasser, P. Bishop and D. Foster. 1996. High-level expression of recombinant human fibrinogen in the milk of transgenic mice. Nat. Biotechnol. 14:867-871.
100. Rijnkels, M., P. M. Kooiman, P. J. A. Krinmpenfort, H. A. de Boer and F. R. Pieper. 1995, Expression analysis of the individual bovine β, αs2- and κ-casein genes in transgenic mice. Biochem. J. 311:929-937.
101. Rokkones, E., S. H. Fromm, B. N. Kareem, H. Klungland, O. K. Olstad, A. Hogset, J. Iversen, K. Bjoro and K. M. Gautvik. 1995. Human parathyroid hormone as a secretory peptide in milk of transgenic mice. J. Cell Biochem. 59:168-176.
102. Rosengard, A. M., N. R. B. Carry, G. A. Langford, A. W. Tucker, J. Wallwork and D. J. G. White. 1995. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgeuic pigs. Transplantation. 59: 1325-1333.
103. Sachs, D. H. and F. H. Bach. 1990. Immunology of xenograft rejection. Hum. Immunol. 28:245-251.
104. Saez, E. D. N. A. West and R. M. Evans. 1997. Inducible gene expression in mammalian cells and transgenic mice. Curr. Opin. Biotech. 8:608-616.
105. Sanders, M. M. and G. S. McKnight. 1988. Positive and negative regulatory elements control the steroid-responsive ovalbumin promoter. Biochemistry. 27:6550-6557.
106. Sandrin, M. S., H. A. Vaughan and I. F. C. McKenzie. 1994. Identification of gal(α1,3)gal as the major epitope for pig-to-human vascularized xenografts. Transplant. Rev. 8:134-149.
107. Schnieke, A. E., A. J. Kind, W. A. Ritchie, K. Mycock, A. R. Scott, M. Ritchie, I. Wilmut, A. Colman and K. H. Campbell. 1997. Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science. 278:2130-2133.
108. Schofield, J. P. and C. T. Caskey. 1995. Non-viral approaches to gene therapy. Br. Med. Bull. 51:56-71.
109. Shani, M., I, Barash, M. Nathan, G. Ricca, G. H. Searfoss, I. Dekel, A. Faerman, D. Givol and D. R. Hurwitz. 1992. Expression of human albumin in the milk of transgenic mice. Transgenic Res. 1:195-208.
110. Soulier, S., M. -G. Stinnakre, L. Lepourry, J. -C. Mercier and J. -L. Vilotte. 1999. Use of doxycycline-controled gene expression to reversibly alter milk-protein composition in transgenic mice. Eur. J. Biochem. 260:533-539.
111. Stromqvist, M., L. M. Houdebine, J. O. Andersson, A. Edlund, T. Johansson, C. Viglietta, C. Puissant and L. Hansson. 1997. Recombinant human extracellular superoxide dismutase produced in milk of transgenic rabbits. Transgenic Res. 6:271-278.
112. Stromqvist M., J. Tornell. M. Edlund, A. Edlund, T. Hohansson, K. Lindgren, L. Lundberg and L. Hannson. 1996. Recombinant human bile-salt-stimulated lipase: an example of defective O-glycosylation of a protein produced in milk of transgenic mice. Transgenic Res. 5: 475-485.
113. Suk, K., D. Y. Jung, S. K. Kang, S. W. Kang, E. J. Seo, H. A. Kand, M. H. Yu and S. J. Seo. 1995. Human erythropoietin-induced polycythemia in transgenic mice. Mol. Cells. 5:634-640.
114. Swanson, M. E., M. J. Martin, J. K. O'Dounell, K. Hoover, W. Lago, V. Huntress, C. T. Parsons, C. A. Pinkert, S. Pilder and J. S. Logan. 1992. Production of functional human hemoglobin in transgenic swine. Bio/Technology 10:557-559.
115. Takizawa, H., K. Takahashi, T. Murakami, N. Okada and H. Okada. 1992. Species-specific restriction of complement by HRF20(CD59) generated by cDNA transfection. Eur. J. Immunol. 22:1943-1946.
116. Tripathy, S. K., H. B. Black, E. Goldwasser and J. M. Leiden. 1996a. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2:545-550.
117. Tripathy, S. K., E. C. Svensson, H. B. Black, E. Goldwasser, M. Margalith, P. M. Hobart and J. M. Leiden. 1996b. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc. Natl. Acad. Sci., USA. 93:10876-10880.
118. Tsai, M. -J. and B. W. O'Malley. 1994. Molecular mechanisms of action of steroid/thyroid receptor superflmily members. Ann. Rev. Biochem. 63:451-496.
119. Udvardy, A., E. Maine and P. Schedl. 1985. The 87A7 chromomere. Identification of novel chromatin structures flanking the heat shock locus that may define the boundaries of higher order domains. J. Mol. Biol. 185: 341-358.
120. Uusi-Oukari, M., J. M. Hyttinen, V. P. Korhonen, A. Vasti, L. Alhonen, O. Janne and J. Janne. 1997. Bovine α s1-casein gene sequences direct high level expression of human granulocyte-macrophage colony-stimulating factor in the milk of tansgenic mice. Transgenic Res. 6:75-84.
121. Velander, W., J. L. Johnson, R. L. Page, C. G. Russell, A. Subramanian, T. D. Wilkins, F. C. Gwazdauskas, C. Pittius and W. N. Drohan. 1992. High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human protein C. Proc. Natl. Acad. Sci., USA. 89:12003-12007.
122. Vile, R. G., A. Tsuzynski and S. Castleden. 1996. Retroviral vectors. From laboratory tools to molecular medicine. Mol. Biotechnol. 5:139-158.
123. Vilotte, J. -L., F. L'Huillier and J. -C. Mercier. 1998. Modification and repression of genes expressed in the mammary gland using gene targeting and other technologies. J. Mamm. Gland Biol. Neopl. 3:351-362.
124. Wakayama, T., A. C. F. Perry, M. Zuccotti, K. R. Johnson and R. Yanagimachi. 1998. Full-term development of mice from enucleated oocytes injected with cumulus cells nuclei. Nature. 394:369-374.
125. Webster, J., G. Donofrio, R. Wallace, A. J. Clark and C. B. A. Whitelaw. 1997. Intronic sequences modulate the sensitivity of β-lactoglobulin transgenes to position effects. Gene. 193:239-243.
126. Wells, D. J. and G. Goldspink. 1992. Age and sex influence expression of plasmid DNA directly injected into mouse skeletal muscle. FEBS Lett. 306:203-205.
127. Werls, D. N., P. N. Misica, T. A. Day and H. R. Tervit 1997. Production of cloned lambs from an established embryonic cell line: a comparison between in vivo- and in vitro-matured cytoplasts. Biol. Reprod. 57:385-393.
128. Whitelaw, C. B. A., A. L. Archibald, S. Harris, M. McClenaghan, J. P. Simons and A. J. Clark. 1991. Targeting expression to the mammary gland: intronic sequences can enhance the efficiency of gene expression in transgenic mice. Transgenic Res. 1:3-13.
129. Wilkins, T. D. and W. Velander. 1992. Isolation of recombinant proteins from milk. J. Cell Biochem. 49: 333-338.
130. Williams, R. S., S. A. Johnston, M. Reidy, M. J. de Vit, S. G. McElligott and J. C. Sanford. 1991. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc. Natl. Acad. Sci., USA. 88:2726-2730.
131. Wilmut, I., A. E. Schnieke, J. McWhir, A. J. Kind and K. H. Campbell. 1997. Viable offspring derived from fetal and adult mammalian cells. Nature. 385:810-813.
132. Wright, G., A. Carver, D. Cotton, D. Reeves, A. Scott, P. Simons, I. Wilmut, I. Garner and A. Colman. 1991. High level expression of active human alpha-1-antitrypsin in the milk of transgenic sheep. Bio/Technology. 9:830-834.
133. Yamazaki, Y., H. Fujimoto, H. Ando, T. Ohyama, Y. Hirota and T. Noce. 1998. In vivo gene transfer to mouse spermatogenic cells by deoxyribonucleic acid injection into seminiferous tubules and subsequent electroporation. Biol. Reprod. 59:1439-1444.
134. Yarus, S., N. M. Greenberg, Y. Wei, J. A. Whitsett, T. E. Weaver and J. M. Rosen. 1997. Secretion of unprocessed human surfactant protein B in milk of transgenic mice Transgenic Res. 6:51-57.
135. Yarus, S., J. M. Rosen, A. M. Cole and G. Diamond. 1996. Production of active bovine tracheal antimicrobial peptide in milk of transgenic mice. Proc. Natl. Acad. Sci., USA. 93:14118-14121.
136. Ye, X., V. M. Rivera, P. Zoltick, F. Cerasoli, Jr., M. A. Schnell, G. Gao, J. V. Hughes, M. Gilman and J. M. Wilson. 1999. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science. 283: 88-91.
137. Yull, F., B. Binas, G. Harold, R. Wallace and A. J. Clark. 1997. Transgenic rescue in the mammary gland is associated with transcription but does not require translation of BLG transgenes. Transgenic Res. 6:11-17.
138. Yull, F., G. Harold. R. Wallace, A. Cowper, J. Percy, I. Cottingham and A. J. Clark. 1995. Fixing human factor IX (fIX): correction of a cryptic RNA splice enables the production of biologically active fIX in the mammary gland of transgenic mice. Proc. Natl. Acad. Sci., USA. 92:10899-10903.
139. Zambrowics, B. P., C. J. Harendza, J. W. Zimmermann, R. L. Brinster and R. D. Palmiter. 1993. Analysis of the mouse protamine 1 promoter in transgenic mice. Proc. Natl. Acad Sci., USA. 90:5071-5075.
140. Zhang, L., L. Li, G. A. Hofmann and R. M. Hoffman. 1996. Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin aging and other diseases. Biochem. Biophys. Res. Common. 220:633-636.
141. Zelenin, A. V., V. A. Kolesnikov, O. A. Tarasenko, R. A. Shafei, I. A. Zelenina, V. V. Mikhailov, M. L. Semenova, D. V. Kovalenko, O. V. Artemyeva, T. E. Ivaschenko, O. V. Evgafov, G. Dlickson and V. S. Baranovand. 1997. Bacterial beta-galactosidase and human dystrophin genes are expressed in mouse skeletal muscle fibers after ballistic transfection. FEBS Lett. 414:319-322.